Cortex

D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-näive patients with schizophrenia

Converging evidence indicates that the prefrontal cortex is critically involved in executive control and that executive dysfunction is implicated in schizophrenia. Reduced dopamine D2/D3 receptor binding potential has been reported in schizophrenia, …

18F-Fallypride binding potential in patients with schizophrenia compared to healthy controls

Background: Molecular imaging of dopaminergic parameters has contributed to the dopamine hypothesis of schizophrenia, expanding our understanding of pathophysiology, clinical phenomenology and treatment. Our aim in this study was to …